Question 1

Am I eligible for this trial based on my treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of Ispinesib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

Question 3

How does Ispinesib compare to other treatment options I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the trial to check my health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

Question 6

How long can I expect to be in this trial, and what happens if my cancer progresses?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer clinical trial (NCT00085813). Contact the study team or your healthcare provider for specific answers.

What this study is about